Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03604263 · ClinicalTrials.gov registry record · NA
ArcticLine Feasibility Study
A NA study of Atrial Fibrillation and Atrial Flutter, sponsored by Medtronic Cardiac Ablation Solutions.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 4
- Study locations
NCT03604263 is a NA study of Atrial Fibrillation and Atrial Flutter that has completed, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 17 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT03604263, a NA study of Atrial Fibrillation and Atrial Flutter, has completed, sponsored by Medtronic Cardiac Ablation Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the ArcticLine Feasibility Study is to collect preliminary safety and effectiveness data on the ArcticLine Catheter.
Conditions Studied
Interventions
- DEVICE ArcticLine Cardiac Cryoablation Catheter
Study Locations (4)
Florida
- BayCare Medical Group Cardiology - Tampa
Michigan
- University of Michigan - Ann Arbor
Pennsylvania
- University of Pittsburgh Medical Center (UPMC) - Pittsburgh
Quebec
- Montreal Heart Institute - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-10-18 |
| Est. Completion | 2019-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03604263
The ClinicalTrials.gov registry entry for NCT03604263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The listed sponsor is Medtronic Cardiac Ablation Solutions, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which ArcticLine Cardiac Cryoablation Catheter is the first listed.
NCT03604263 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Michigan, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03604263 about?
NCT03604263 is a clinical study titled "ArcticLine Feasibility Study". The purpose of the ArcticLine Feasibility Study is to collect preliminary safety and effectiveness data on the ArcticLine Catheter.
What is the current status of trial NCT03604263?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2018-10-18. Estimated completion is 2019-11-18.
What conditions does trial NCT03604263 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter.
What interventions are being tested in trial NCT03604263?
The interventions under investigation include: ArcticLine Cardiac Cryoablation Catheter (DEVICE).
Who is sponsoring clinical trial NCT03604263?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03604263 being conducted?
This trial has 4 study locations across Florida, Michigan, Pennsylvania, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.